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aBsTRacT
The cultivation of sugarcane hybrids (X Saccharum officinarum L.) is an important revenue source 
for the Brazilian economy. Herein it is reported the evaluation of the cytotoxic activity of mid-polarity 
sugarcane extracts against human cancer cell lines, as well as the isolation of steroids sitosterol, 
stigmasterol and campesterol, phenolic acids p-hydroxybenzoic, p-hydroxycinnamic, vanillic and ferulic 
acid, terpenoids α-tocopherol and β-carotene and a novel substance in sugarcane, the flavonoid aglycone 
tricin (5,7,4-trihydroxy-3,5-dimethoxyflavone). The presence of large amounts of phenolic acids and the 
flavonoid tricin may explain the cytostatic activity observed for the mid-polarity crude extract and filtrates. 
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inTRoducTion
Sugarcane (Saccharum officinarum L., Poaceae), 
a grass native to Asia, is widely found in tropical 
regions and it is one of the most important cultures 
in Brazil, with an annual production of over 375 
million tons (Conab 2013). It is widely used in 
sugar and alcohol production, yielding high quality 
at a low price for both products. Sugarcane is used 
to produce brown sugar bars (rapadura), molasses, 
rum (cachaça), in addition to its juice (garapa), 
which is largely consumed in Brazil. 
Besides its great economic importance for food 
and fuel production, the literature reports medicinal 
properties for S. officinarum preparations, such 
as antidiabetic (Takahashi et al. 1985) and anti-
mutagenicity (Yamashita et al. 1993) activities, as 
well as its use in osteoporosis treatment (Barros et 
al. 2007), usually associated with the juice prepared 
from the culms. The Ayurveda cites the use of this 
species to treat anemia, inflammations and ulcers 
(Chatterjee and Pakrashi 1995).
The most common phenolic compounds 
found in S. officinarum belong to the flavone class, 
such as naringenin, apigenin, tricin and luteolin 
derivatives (Williams et al. 1974, López-Lázaro 
2009). These compounds are partly responsible for 
the sugarcane juice color and are acknowledged to 
have beneficial health effects associated with their 
high antioxidant potential and capacity to protect 
cells from degenerative processes and reduce the 
development of cancer and cardiovascular diseases. 
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Phytochemical studies reported the presence 
and biological potential of these sugarcane 
compounds. A bioguided study of the juice from 
culms of S. officinarum led to isolation of the 
flavone tricin-7-O-β-(6’’-methoxycinnamic)-
glycoside, which has shown considerable 
antiproliferative and antioxidant potential (Almeida 
et al. 2007). Other studies have shown that extracts 
of sugarcane leaves could improve health quality, 
decreasing the incidence of diseases due to their 
antioxidant properties (Abbas et al. 2013). Other 
phytochemical studies reported the presence of 
flavonoid glycosides (Colombo et al. 2005, 2006a, 
b, Walford et al. 2009), wherever this class of 
natural products has been considered fundamental 
to human health. 
In addition to the isolated flavonoids, other 
important bioactive compounds have been 
found in this species, such as hydroxamic acids, 
hydroxycinnamic acids, alpha hydroxy acids, 
aliphatic acids and polyamides (Loyd and Naidoo 
1983). Alpha hydroxy acids are used in cosmetics 
for peeling (Ruciani 1997), in dermatology as a 
photoprotector and an anti-inflammatory (Perricone 
and Dinardo 1996). In the last years, the phenolic 
compounds of S. officinarum gained increasing 
attention regarding their antioxidant potential. The 
literature suggests the use of sugarcane as a dietary 
source of antioxidants, flavonoids like luteolin-
8-C-(rhamnosyl glucoside), diosmentin-8-C-
glucoside, vitexin, schaftoside, isoschaftoside and 
4’,5’-dimethyl-luteolin-8-C-glucoside, the major 
compounds responsible for this activity (Vila et al. 
2008). Recent studies have reported this property 
(Ahmad et al. 2011, Duarte-Almeida et al. 2011).
The presence of anthocyanins in the methanolic 
crude extract from S. officinarum was recently 
reported (Pallavi et al. 2012). The same study 
demonstrated that the highly polar crude extract 
has cytotoxic potential against HT29 human colon 
cancer cells. 
Although the presence of bioactive 
substances in highly polar sugarcane extracts is 
well known, little is known about mid-polarity 
extract compounds and their anticancer potential. 
Therefore, the antiproliferative activity of the 
ethyl acetate extract and fractions and the isolation 
of chemical constituents from the leaves of S. 
officinarum commercially cultivated in Brazil are 
reported herein.
maTeRials and meThods
General experimental procedures
NMR spectra were obtained with a Varian 
spectrometer, model Mercury plus BB, operating at 
300.06 MHz for 1H and 75.5 MHz for 13C. Chemical 
shifts were recorded in ppm with reference to 
internal tetramethylsilane (TMS δ = 0.0 ppm). The 
solvents used were CDCl3 and CD3OD (Aldrich). 
Column chromatography (CC) was performed using 
silica gel 60 (Merck) or Sephadex LH-20 (Sigma). 
For thin layer chromatography (TLC), either silica 
gel 60 G or 60 GF254 (Merck) were employed. 
TLC spots were visualized by spraying an acetic 
acid/H2SO4/anysaldehyde solution (1:0.5:48.5 mL) 
followed by plate heating. 
Gas chromatography coupled to mass 
spectrometry analyses were performed in a Focus 
GC (Thermo Finnigan) gas chromatograph coupled 
to a DSQ II (Thermo Finnigan) mass selective 
detector working with 70eV electron impact, fitted 
with a quadrupole type analyzer and an electron 
impact detector (FID). High-purity helium was 
used as mobile phase with a column flow of 
1 mL min-1. The analyses were performed with the 
injector working at 250 ºC and splitless injection. 
The capillary column used was DB-5 (30m x 
0.25mm x 0.25µm) and the oven temperature 
program was from 100 °C to 290 ºC at 10 ºC min-1. 
Sample aliquots were prepared from 1 mg of each 
compound dissolved in 1 mL of ethyl acetate 
(HPLC grade).
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suGarcane samples, preparation and extract 
purification
Saccharum officinarum samples were harvested 
from a commercial culture in the city of Munhoz 
de Mello, Paraná, Brazil. The material (4.36 kg) 
was crushed and exhaustively extracted with ethyl 
acetate at room temperature, yielding 72.00 g of 
crude extract. The extract was submitted to partition 
on a silica gel column eluted with hexane (7.64 g), 
ethyl acetate (33.75 g) and methanol (7.72 g). 
isolation of chemical constituents
Part of the hexane partition (1.0 g) was submitted 
to silica gel column chromatography with hexane, 
chloroform and methanol in increasing polarity 
gradient. This procedure yielded β-carotene (1, 
3.9 mg). 
Silica gel column chromatography of the 
ethyl acetate partition (32.00 g) with hexane, 
hexane:dichloromethane, dichloromethane, 
dichloromethane:ethyl acetate, ethyl acetate, 
ethyl acetate:methanol and methanol in increasing 
polarity gradient yielded 548 fractions. The 
fractions eluted with CH2Cl2:AcOEt (85:15) were 
combined and washed with ethyl acetate, leading 
to the isolation of flavonoid tricin (8, 55.0 mg). 
The fractions eluted with CH2Cl2:AcOEt (3:2) 
were combined, washed with cold propanone and 
yielded compound sitosterol glucoside (9, 104.2 
mg).
Similarly, part of the fractions eluted with 
CH2Cl2:AcOEt (9:1) were combined and purified 
in Sephadex LH 20 with methanol as eluent. This 
procedure led to the isolation of a mixture of 
p-hydroxycinnamic and p-hydroxybenzoic acids 
(10 and 11, 33.5 mg). The fractions eluted with 
100% dichloromethane were combined and washed 
with ethyl acetate and methanol and yielded a 
mixture of steroids sitosterol, stigmasterol and 
campesterol (2-4, 30.0 mg). After, the remaining 
dough of fractions combined (2.08 g) was submitted 
to silica gel column chromatography with hexane, 
chloroform and methanol in increasing polarity 
gradient yielding the compound α-tocopherol (5, 
3.6 mg). The fractions eluted with HCCl3:MeOH 
20% were combined and purified in silica gel 
column chromatography with hexane, ethyl acetate 
and methanol in increasing polarity gradient. This 
procedure yielded compounds vanillic acid (6, 6.0 
mg) and ferulic acid (7, 5.0 mg). 
spectral data of the compounds 1-11 obtained in 
this Work
Sitosterol (2). GC-MS (EI, 70 eV) m/z: 414. 31 (M+ 
1), 55.00 (100), 69.01 (93.3), 83.05 (79.8), 80.99 
(76.0 ). 1H NMR (300.06 MHz, CDCl3). δ 3.47 (1H, 
m, H-3), 5.36 (1H, d; 5.1, H-6), 0.68 (3H, s, H-18), 
1.01 (3H, s, H-19), 0.93 (3H, s, H-21), 0.84 (3H, s, 
H-26), 0.81 (3H, s, H-27), 0.87 (3H, s, H-29).  13C 
NMR (75.5 MHz, CDCl3): δ 37.4 (C-1), 31.8 (C-
2), 72.0 (C-3), 42.5 (C-4), 140.9 (C-5), 121.9 (C-
6), 31.8 (C-7), 32.1 (C-8), 50.3 (C-9), 36.3 (C-10), 
21.2 (C-11), 39.8 (C-12), 42.5 (C-13), 56.9 (C-14), 
24.5 (C-15), 28.4 (C-16), 56.2 (C-17), 12.0 (C-18), 
19.6 (C-19), 36.1 (C-20), 19.6 (C-21), 33.9 (C-22), 
39.2 (C-23), 46.0 (C-24), 29.1 (C-25), 18.9 (C-26), 
19.6 (C-27), 23.2 (C-28), 12.2 ppm (C-29).
Stigmasterol (3). GC-MS (EI, 70 eV) m/z: 
412.26 (M+ 2), 43.02 (100), 105.01 (84.9), 95.05 
(84.6), 107.03 (93.59). 1H NMR (300.06 MHz, 
CDCl3). δ 3.47 (1H, m, H-3),  5.36 (1H, d; 5.1, 
H-6), 4.97 (1H, dd; 8.4, H-22), 5.19 (1H, dd; 8.4, 
H-23), 0.68 (3H, s, H-18), 1.01 (3H, s, H-19), 0.93 
(3H, s, H-21),  0.84 (3H, s, H-26), 0.81 (3H, s, 
H-27), 0.87 (3H, s, H-29). 13C NMR (75.5 MHz, 
CDCl3): δ 37.4 (C-1), 31.8 (C-2), 72.0 (C-3), 42.5 
(C-4), 140.9 (C-5), 121.9 (C-6), 31.8 (C-7), 32.1 
(C-8), 50.3 (C-9), 36.3 (C-10), 21.2 (C-11), 39.8 
(C-12), 42.5 (C-13), 56.9 (C-14), 24.5 (C-15), 28.4 
(C-16), 56.1 (C-17), 12.0 (C-18), 19.6 (C-19), 40.7 
(C-20), 21.4 (C-21), 138.5 (C-22), 129.4 (C-23), 
51.4 (C-24), 31.8 (C-25), 19.2 (C-26), 19.2 (C-27), 
25.6 (C-28), 12.4 ppm (C-29).
An Acad Bras Cienc (2016) 88 (3)
1204 VANESSA G. ALVES et al.
Campesterol (4). GC-MS (EI, 70 eV) m/z: 
400.28 (M+ 71.7), 43.97 (100), 43.03 (60.9), 
145.07 (45.0), 95.06 (39.9). 1H NMR (300.06 
MHz, CDCl3).  δ 3.47 (1H, m, H-3), 5.36 (1H, d; 
5.1, H-6), 0.68 (3H, s, H-18), 1.01 (3H, s, H-19), 
0.93 (3H, s, H-21), 0.84 (3H, s, H-26), 0.81 (3H, 
s, H-27), 0.78 (3H, s, H-28). 13C NMR (75.5 MHz, 
CDCl3). δ 37.4 (C-1), 31.8 (C-2), 72.0 (C-3), 42.5 
(C-4), 140.9 (C-5), 121.9 (C-6), 31.8 (C-7), 32.1 
(C-8), 50.3 (C-9), 36.3 (C-10), 21.2 (C-11), 39.9 
(C-12), 42.5 (C-13), 56.9 (C-14), 24.5 (C-15), 28.4 
(C-16), 56.2 (C-17), 12.0 (C-18), 19.6 (C-19), 36.1 
(C-20), 18.9 (C-21), 33.9 (C-22), 29.1 (C-23), 56.1 
(C-24), 29.6 (C-25), 18.9 (C-26), 19.6 (C-27), 18.9 
ppm (C-28).
Tricin (8). GC-MS (EI, 70 eV) m/z: 329.91 
(M+ 100), 152.90 (11.4), 43.98 (9.8), 151.04 (8.45), 
206.92 (7.44). 1H NMR (300.06 MHz, CD3OD/
CDCl3). δ 7.19 (s, H-2’ and 6’), 6.60 (s, H-3), 
6.23 (d; 2.1, H-6), 6.46 (d; 2.1, H-8), 3.98 ppm (s, 
3’-OCH3 and 5’-OCH3). 
13C NMR (75.45 MHz, 
CD3OD/CDCl3). δ 165.3 (C2), 104.9 (C-3), 183.1 
(C-4), 162.4 (C-5), 99.0 (C-6), 164.9 (C-7), 94.8 
(C-8), 158.2 (C-9), 104.8 (C-10), 104.4 (C-2’), 
148.7 (C-3’), 140.2 (C-4’), 148.7 (C-5’), 104.4 (C-
6’), 56.0 ppm (3’-OCH3 and 5’-OCH3).
p-hydroxycinnamic acid (10). GC-MS (EI, 70 
eV) m/z: 163.98 (M+ 100), 163.99 (41.5), 162.97 
(39.8), 118.99 (25.5), 117.97 (23.3). 1H NMR 
(300.06 MHz, CD3OD/CDCl3). δ 7.45 (2H, dt; J= 
8.4 e 4.8 Hz, H-2 e H-6) 6.81 (2H, dt; J= 8.4 e 4.8 
Hz, H-3 e H-5),  6.30 (1H, d; J= 15 Hz; H-8), 7.62 
ppm (1H, d; J= 15 Hz; H-7). 13C NMR (75.5 MHz, 
CD3OD/CDCl3). δ 127.2 (C-1), 131.0 (C-2, C-6), 
116.0 (C-3, C-5), 161.1 (C-4), 146.6 (C-7), 115.6 
(C-8), 170.0 ppm (C=O).
p-hydroxybenzoic acid (11). GC-MS (EI, 70 
eV) m/z: 137.94 (M+ 5.1), 120.94 (100), 137.94 
(70.3), 64.98 (16.4), 121.97 (7.9 ). NMR 1H (300.06 
MHz, CD3OD/CDCl3). 7.90 (2H, dt; J= 8.4 e 4.8 
Hz, H-2 e H-6), 6.81 (2H, dt; J= 8.4 e 4.8 Hz, H-3 
e H-5). 13C NMR (75.45 MHz, CD3OD/CDCl3). δ 
131.0 (C-1), 132.9 (C-2, C-6), 116.7 (C-3, C-5), 
163.3 (C-4), 171.0 ppm (C=O).
Ferulic acid (7). GC-MS (EI, 70 eV) m/z: 
193.97 (M+ 100), 43.97 (20.6), 178.94 (19.4), 
132.94 (17.5), 192.98 (11.3). 1H NMR (300.06 
MHz, CD3OD) δ 7.17 (1H, d, 2.1 Hz, H-2), 6.80 
(1H, d; 8.4 Hz, H-5) 7.06 (1H, dd; 8.4 e 2.1 Hz, 
H-6), 7.58 (1H, d, 15.9 Hz, H-7), 6.33 (1H, d, 15.9 
Hz), 3.87 (OCH3). 
13C NMR (75.45 Hz, CD3OD), δ 
128.6 (C-1), 111.5 (C-2), 151.9 (C-3), 149.3 (C-4), 
116.4 (C-5), 123.0 (C-6), 146.2 (C-7), 116.9 ( C-8), 
56.4 (OCH3), 171.0 ppm ( C-9).
Vanillic acid (6). GC-MS (EI 70 eV) m/z 
167.95 (M+ 100), 152.98 (80.1), 96.92 (25.8), 
124.94 (21.6), 150.98 (18.3). 1H NMR (300.06 
MHz, CD3OD) δ 7.54 (2H, m, H-2 e H-6), 6.84 
(1H, d; 8.7 Hz, H-5), 3.88 ppm (3H, s, OCH3). 
13C 
NMR (75.45 Hz, CD3OD) δ 128.4 (C-1), 113.7 (C-
2), 151.9 (C-3), 152.7 (C-4), 115.8 (C-5), 125.5 
(C-6), 170.0 (C-7), 56.4 ppm (OCH3).
α-tocopherol (5). GC-MS (EI, 70 eV) m/z: 
430.28 (M+ 70.8), 165.03 (100), 164.03 (34.4), 
166.04 (12.2), 205.04 (11.4). 1H NMR (300.06 
MHz, CDCl3). δ 2.61 (2H, t; 6.9, H-4), 1.78 (2H, 
m, H-3), 2.17 (3H, s, H-8b), 2.12 (3H, s, H-7a), 
1.59 (3H, s, H-5a), 1.26 (3H, s, H-2a), 0.88 (3H, 
s, H-4’a), 0.87 (3H, s, H-8’a), 0.85 (6H, s, H-12’a 
and H-13’a)  13C NMR (75.45 MHz, CDCl3) δ 
145.7 (C-8a), 122.8 (C-8), 118.7 (C-7), 11.5 (C-
7a), 144.7 (C-6), 117.6 (C-5), 12.0 (C-5a), 121.9 
(C-4a), 24.7 (C-4), 31.7 (C-3), 74.7 (C-2), 39.6 (C-
1’), 24.7 (C-2’), 37.3 (C-3’, 4’,5’,7’, 8’, 9’), 25.0 
(C-6’), 24.6 (C-10’), 39.9 (C-11’), 28.2 (C-12’), 
22.9 (C-12’a, 13’), 19.9 (C-8’a, 4’a), 24.0 (C-2a), 
12.4 ppm (C-8b).
Sitosterol glucoside (9). GC-MS (EI, 70 eV) 
m/z: 414.31 (M+ 0), 43.95 (100), 206.93 (17.5), 
43.01 (15.1), 164.96 (6.4). 1H NMR (300.06 MHz, 
CD3OD/CDCl3). δ 3.37 (1H, m, H-3), 5.32 (1H, d; 
5.1, H-6), 0.67 (3H, s, H-18), 1.03 (3H, s, H-19), 
0.92 (3H, s, H-21), 0.84 (3H, s, H-26), 0.83 (3H, s, 
H-27), 0.89 (3H, s, H-29), 4.40 (1H, d; 8.1, H-1’), 
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3.53 (1H, m, H-2’), 3.46 (1H, m, H-3’), 3.35 (1H, 
m, H-4’), 3.70 (1H, m, H-5’), 3.54 (1H, m, H-6’a), 
4.06 (1H, m, H-6’b).13C NMR (75.5 MHz, CD3OD) 
δ 37.5 (C-1), 32.7 (C-2), 79.7 (C-3), 43.0 (C-4), 
141.3 (C-5), 122.7 (C-6), 32.7 (C-7), 32.8 (C-8), 
51.1 (C-9), 36.9 (C-10), 21.8 (C-11), 39.4 (C-12), 
43.0 (C-13), 56.8 (C-14), 25.0 (C-15), 29.0 (C-16), 
57.6 (C-17), 12.3 (C-18), 19.8 (C-19), 36.9 (C-20), 
20.5 (C-21), 34.7 (C-22), 40.6 (C-23), 46.7 (C-24), 
29.0 (C-25), 19.8 (C-26), 21.8 (C-27), 23.8 (C-28), 
12.7 (C-29), 102.0 (C-1’), 74.5 (C-2’), 78.7 (C-3’), 
71.1 (C-4’), 77.1 (C-5’), 62.5 ppm (C-6’).
β-carotene (1). GC-MS (EI, 70 eV) m/z: 536.97 
(M+ 0), 43.99 (100), 43.04 (18.1), 55.02 (13.9), 
57.04 (11.9). 1H NMR (300.06 MHz, CDCl3). δ 
2.02 (4H, m, H-4 and H-4’), 1.64 (4H, m, H-3 and 
H-3’), 1.46 (4H, m, H-2 and H-2’), 1.03 (6H, s, 
H-16 and H-16’), 1.04 (6H, s, H-17 and H-17’), 
1.72 (6H, s, H-18 and H-18’), 1.97 (6H, s, H-19 and 
H-19’), 2.05 (6H, s, H-20 and H-20’).  13C NMR 
(75.45 MHz, CDCl3) δ 34.5 (C-1/1’), 39.9 (C-2/2’), 
19.5 (C-3/3’), 33.3 (C-4/4’), 129.6 (C-5/5’), 137.9 
(C-6/6’), 126.6 (C-7/7’), 137.5 (C-8/8’), 136.7 (C-
9/9’), 131.1 (C-10/10’), 125.2 (C-11/11’), 137.2 
(C-12/12’), 136.7 (C-13/13’), 132.6 (C-14/14’), 
129.6 (C-15/15’), 29.2 (C-16/16’, 17/17’), 22.7 (C-
18/18’), 12.9 (C-19/19’), 12.9 ppm (C-20/20’).
In vitro anticancer assay
The in vitro anticancer assays of the ethyl acetate 
extract and its hexane, ethyl acetate and methanol 
partitions and pure flavonoid tricin were performed 
as described in the literature (Monks et al. 1991). 
Eight human tumor cell lines [U251 (glioma), MCF-
7 (breast), NCI-ADR/RES (multiple drug resistant 
ovary cells), 786-0 (kidney), NCI-H460 (lung, 
non-small cells), PC-3 (prostate), OVCAR-03 
(ovary) and colon (HT29)] were kindly provided 
by Frederick MA, National Cancer Institute/
USA. HaCat (human keratinocytes) cell line was 
kindly donated by Dr. Ricardo Della Coletta (FOP, 
UNICAMP). Stock and experimental cultures 
were grown in media containing 5 mL RPMI 1640 
(GIBCO BRL) supplemented with 5 % fetal bovine 
serum (GIBCO BRL). A penicillin:streptomycin 
mixture (1000 μg mL-1 : 1000 μg mL-1, 1 mL L-1 
RPMI) was added to the experimental cultures. 
Cells plated to 96-well plates (100 μL cells well-1) 
were exposed to different sample concentrations 
in DMSO/RPMI (0.25, 2.5, 25 and 250 μg mL-1) 
at 37 °C under 5% CO2 in air for 48 h. The final 
DMSO concentration did not affect cell viability. 
The cells were fixed with 50% trichloroacetic 
acid before (T0 plate) and after (T1 plates) sample 
addition. Cell proliferation was determined by 
spectrophotometric quantification (540 nm) of cell 
protein content using the sulforhodamine B assay. 
Using the concentration-response curve for each 
cell line, the GI50 (concentration resulting in growth 
inhibition of 50%) was determined through non-
linear regression analysis in software ORIGIN 8.0 
(OriginLab Corporation) (Shoemaker 2006).
ResulTs and discussion
β-carotene (1), steroids sitosterol (2), stigmasterol 
(3) and campesterol (4), α-tocopherol (5), vanillic 
(6) and ferulic acids (7),  tricin (8), sitosterol 
glucoside (9) and p-hydroxycinnamic (10) and 
p-hydroxybenzoic acids (11) (Figure 1) were 
isolated from the ethyl acetate extract and identified 
by interpretation of 1H, 13C, DEPT and COSY NMR 
spectral data and comparison with literature data 
(Miranda et al. 2012, Goulart et al. 1993, Yu et al. 
2006, Sajjadi et al. 2012, Chung et al. 2005, Lee et 
al. 2007, Silva et al. 2001, Scott 1972).
The molecular formula of compound 8, 
C17H14O7, was established by GC-MS analysis [m/z 
329.91]. Its 1H NMR spectrum presented signals 
characteristic of a substance belonging to the 
flavonoid class, of which the following stand out 
the singlet at δH 7.19 relative to hydrogens H-2’ and 
H-6’ of ring B and doublets at δH 6.46 (J= 2.1 Hz) 
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and 6.23 (J= 2.1 Hz), corresponding to hydrogens 
H-8 and H-6 of ring A, and a singlet at δH 6.60 
attributed to hydrogen H-3. The 13C NMR spectrum 
showed resonances at δC 158.6, 94.8, 164.9, 99.6, 
162.2 and 104.9, attributed to carbons C-9, C-8, 
C-7, C-6, C-5 and C-10 of ring A, respectively. 
Furthermore, a signal at δC 183.1, characteristic of 
the carbonyl 1,4-pirone system, and signals in the 
δC 122.0-165.3 region, attributed to ring B carbons, 
were observed. The signals at δC 104.9 and 165.3, 
corresponding to carbons C-3 and C-4 of ring C, 
are typical of flavone aglycone. These data were 
compared with data in the literature (Khadem and 
Marles 2010) and were consistent for tricin. 
The ethyl acetate extract from young leaves 
and culms of S. officinarum and the hexane, ethyl 
acetate and methanol partitions from the ethyl 
acetate extract were tested at concentrations 
ranging from 0.25 to 250 µg/mL against 08 
different human tumor cell lines [glioma (U521), 
breast (MCF-7), resistant ovary (NCI/ADR-RES), 
kidney (786-0), lung (NCI-H460), prostate (PC-
3), ovary (OVCAR-3) and colon (HT29)] and non-
tumoral human keratinocyte (HaCat) cell lines 
using a colorimetric method for growth inhibition 
evaluation (Table I). Doxorubicin was used as a 
positive control.
Human cell lines: A = U251 (glioma, SNC); B 
= MCF-7 (breast); C = NCI-ADR/RES (multiple 
drug resistant ovary cells); D = 786-0 (kidney); 
E = NCI-H460 (lung); F = PC-3 (prostate); G = 
OVCAR-3 (ovary); H = HT29 (colon); Q = HaCat 
(normal human keratinocytes). *Doxorubicin: 
reference chemotherapy; GI50: Concentration 
necessary for 50% cell growth inhibition.
In general, the ethyl acetate extract showed 
cytostatic activity in concentrations ranging from 
25.8 to 61.8 µg/mL. Similar activity was noticed 
for the ethyl acetate partition, suggesting that the 
compounds responsible for this biological activity 
were concentrated in this fraction. Corroborating 
these results, the hexanic and methanolic fractions 
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Figure 1 - Phenolic compounds isolated from sugarcane.
An Acad Bras Cienc (2016) 88 (3)
 PHENOLIC COMPOUNDS IN SUGARCANE 1207
showed a comparatively lower activity, being 
inactive (GI50 > 250 µg/mL) against almost all 
cell lines (Table I). Thus, fractionation of the ethyl 
acetate fraction was prioritized.
Of the compounds isolated from the ethyl 
acetate fraction, flavonoid tricin was evaluated 
against the same cell line panel. Tricin showed 
cytostatic activity against two ovarian cancer cell 
lines, OVCAR-3 (GI50 = 41.1 µg/mL) and NCI-
ADR/RES (GI50 = 70.3 µg/mL). As observed for 
doxorubicin, tricin also inhibited cell growth of 
non tumoral human keratinocytes (HaCat, GI50 = 
69.6 µg/mL). Therefore, this result partly explains 
the biological activity observed for the ethyl acetate 
crude extract and the ethyl acetate fraction. 
Based on literature results (Kampa et al. 
2003, Lee 2005, Pugazhendhi et al. 2005) for 
the other phenolic compounds isolated from the 
bioactive ethyl acetate fraction (p-hydroxybenzoic, 
p-hydroxycinnamic, vanillic and ferulic acid), it 
is possible to postulate the involvement of these 
compounds in the cytostatic activity observed 
for the ethyl acetate crude extract and the ethyl 
acetate fraction. (Cai et al. 2004) evaluated 
tricin in a xenographic breast tumor model and 
observed that treating animals with tricin (0.2% 
w/w in diet) for 7 days before tumor cell (MDA-
MB-468) implantation did not reduce tumor 
growth, but tricin treatment (72 h, 11µM) before 
MDA-MB-468 tumor cell implantation in nude 
mice resulted in smaller tumors when compared to 
untreated cells. Besides, extracts containing high 
tricin concentrations are known to inhibit human 
colon and breast cancer cell proliferation (Hudson 
et al. 2000). There is also evidence that tricin has 
chemopreventive activity, such as observed in 
intestinal carcinogenesis models in mice (Cai et al. 
2005).
The phytochemical study of the leaves 
and culms of Saccharum officinarum led to the 
isolation of eleven compounds belonging to 
different classes. Their structures were identified 
based on GC-MS and NMR methods. The tricin 
showed significant anticancer activity in the in vitro 
anticancer assay. Therefore, the present isolation 
of tricin corroborates anticancer studies, pointing 
to the optimization of the production of tricin from 
this new source for important pharmacological 
studies. Sugarcane may also be an important source 
of tricin derivatives which may be used to produce 
the bioactive aglycone by hydrolysis.
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TaBle i 
Gi50 (µg/ml) for the S. officinarum crude ethyl acetate extract and partitions for cancer cell lines.
a B c d e F G h Q
doxorubicin * < 0.025 < 0.025 0.025 0.20 < 0.025 0.082 0.28 0.12 0.025
etac extract 29.0 25.8 25.4 31.8 28.7 47.8 57.9 61.8 26.1
hexane part. > 250 164.0 162.5 > 250 > 250 > 250 > 250 > 250 > 250
etac part. 29.1 26.1 5.9 65.4 51.7 30.3 52.4 35.0 34.2
methanol part. > 250 67.2 > 250 > 250 > 250 > 250 > 250 > 250 > 250
pure tricin > 250 > 250 70.3 > 250 127.7 > 250 41.1 > 250 69.6
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